Inhibition of CYP1A1 by pharmaceutical drugs, omeprazol and ketoconazole as a mechanism for activation of aryl hydrocarbon receptor (AHR)

Inhibition of CYP1A1 by pharmaceutical drugs, omeprazol and ketoconazole as a mechanism for activation of aryl hydrocarbon receptor (AHR)

Show other versions (1)

<p>Omeprazole (OMP) and ketoconazole (KTZ) have been shown to activate the AHR signaling pathway in spite of the fact that they bind to the receptor with low or no affinity. The aim of this study was to investigate whether KTZ and OMP can act as indirect activator of AHR. In order to evaluate...

Full description

Bibliographic Details
Main Authors: Ali Ghaffarian-Bahraman, Nilofar Sadeghimanesh, Mona Mirzaei, Amin-Reza Akbarizadeh, Mahmoud Omidi, Hamidreza Mohammadi, Mohammad-Reza Arabnezhad, Keivan Mobini, Afshin Mohammadi-Bardbori
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2017-03-01
Series:Trends in Pharmaceutical Sciences
Subjects:
CYP1A1, omeprazol, ketoconazole, aryl hydrocarbon receptor (AHR), FICZ
Online Access:http://tips.sums.ac.ir/index.php/TiPS/article/view/110

Internet

http://tips.sums.ac.ir/index.php/TiPS/article/view/110

Similar Items